Circulating tumor cells for comprehensive and multiregional non-invasive genetic characterization of multiple myeloma
- 1 June 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Leukemia
- Vol. 34 (11), 3007-3018
- https://doi.org/10.1038/s41375-020-0883-0
Abstract
Multiple myeloma (MM) patients undergo repetitive bone marrow (BM) aspirates for genetic characterization. Circulating tumor cells (CTCs) are detectable in peripheral blood (PB) of virtually all MM cases and are prognostic, but their applicability for noninvasive screening has been poorly investigated. Here, we used next-generation flow (NGF) cytometry to isolate matched CTCs and BM tumor cells from 53 patients and compared their genetic profile. In eight cases, tumor cells from extramedullary (EM) plasmacytomas were also sorted and whole-exome sequencing was performed in the three spatially distributed tumor samples. CTCs were detectable by NGF in the PB of all patients with MM. Based on the cancer cell fraction of clonal and subclonal mutations, we found that ~22% of CTCs egressed from a BM (or EM) site distant from the matched BM aspirate. Concordance between BM tumor cells and CTCs was high for chromosome arm-level copy number alterations (≥95%) though not for translocations (39%). All high-risk genetic abnormalities except one t(4;14) were detected in CTCs whenever present in BM tumor cells. Noteworthy, ≥82% mutations present in BM and EM clones were detectable in CTCs. Altogether, these results support CTCs for noninvasive risk-stratification of MM patients based on their numbers and genetic profile.This publication has 30 references indexed in Scilit:
- The multiple myelomas — current concepts in cytogenetic classification and therapyNature Reviews Clinical Oncology, 2018
- Spatial genomic heterogeneity in multiple myeloma revealed by multi-region sequencingNature Communications, 2017
- Circulating tumour DNA sequence analysis as an alternative to multiple myeloma bone marrow aspiratesNature Communications, 2017
- Liquid biopsies come of age: towards implementation of circulating tumour DNANature Reviews Cancer, 2017
- Circulating tumour DNA analysis demonstrates spatial mutational heterogeneity that coincides with disease relapse in myelomaLeukemia, 2016
- Genetic interrogation of circulating multiple myeloma cells at single-cell resolutionScience Translational Medicine, 2016
- Cell-free DNA Comprises an In Vivo Nucleosome Footprint that Informs Its Tissues-Of-OriginCell, 2016
- Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working GroupJournal of Clinical Oncology, 2015
- Heterogeneity of genomic evolution and mutational profiles in multiple myelomaNature Communications, 2014
- Impact of primary molecular cytogenetic abnormalities and risk of progression in smoldering multiple myelomaLeukemia, 2013